Literature DB >> 11163039

Reproducibility of visual activation in functional magnetic resonance imaging at very high field strength (4 Tesla).

A Miki1, J Raz, S A Englander, N S Butler, T G van Erp, J C Haselgrove, G T Liu.   

Abstract

PURPOSE: The reproducibility of functional magnetic resonance imaging (fMRI) has been studied on 1.5 Tesla (T) (high field strength) scanners. We report the reproducibility of visual activation in fMRI at 4 T (very high field strength).
METHODS: Five healthy subjects were scanned twice in the same session with a 4 T scanner during binocular flashing visual stimulation. The activated areas during the first and second acquisition were compared.
RESULTS: Activation of the visual cortex was observed in all subjects and activation of lateral geniculate nucleus was also detected in four subjects. The ratio of overlapping activated voxels in the first and second acquisition was 0.81 +/- 0.05.
CONCLUSIONS: Reproducibility of visual activation using fMRI at 4 T was found to be acceptable, and the results from 4T scanners show a reliability similar to those at 1.5 T.

Mesh:

Year:  2001        PMID: 11163039     DOI: 10.1016/s0021-5155(00)00304-x

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  5 in total

1.  Reproducibility of functional MR imaging results using two different MR systems.

Authors:  Erik-Jan Vlieger; Cristina Lavini; Charles B Majoie; Gerard J den Heeten
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

2.  Within-subject reproducibility of category-specific visual activation with functional MRI.

Authors:  Marius V Peelen; Paul E Downing
Journal:  Hum Brain Mapp       Date:  2005-08       Impact factor: 5.038

3.  Stability of tactile- and pain-related fMRI brain activations: an examination of threshold-dependent and threshold-independent methods.

Authors:  Keri S Taylor; Karen D Davis
Journal:  Hum Brain Mapp       Date:  2009-07       Impact factor: 5.038

4.  Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.

Authors:  Maura L Furey; Wayne C Drevets; Elana M Hoffman; Erica Frankel; Andrew M Speer; Carlos A Zarate
Journal:  JAMA Psychiatry       Date:  2013-03       Impact factor: 21.596

5.  Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.

Authors:  Maura L Furey; Wayne C Drevets; Joanna Szczepanik; Ashish Khanna; Allison Nugent; Carlos A Zarate
Journal:  Int J Neuropsychopharmacol       Date:  2015-03-28       Impact factor: 5.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.